Muscle fibers secrete and concentrate a protein called fibroblast growth factor binding protein 1 (FGFBP1) at the neuromuscular junctions, the area of contact between motor neurons and muscle fibers, according to a study published in the Journal of Neuroscience.
The Focused Ultrasound Foundation has recognized Sunnybrook Health Sciences Centre in Toronto, Canada, as a Centre of Excellence for accelerating research progress through collaboration to treat diseases like those of the central nervous system, such as amyotrophic lateral sclerosis (ALS). “With an unparalleled team of scientists and clinicians, Sunnybrook…
Being diagnosed with amyotrophic lateral sclerosis (ALS) is a difficult and stressful time. You’ll probably feel incredibly overwhelmed in the first few days and weeks, and struggle to understand the ramifications involved. To help with the process, we’ve compiled a list of tips for patients who have recently been diagnosed with…
Researchers have developed a new approach that might help ALS patients maintain their ability to communicate as disease progresses, according to a study published in the Journal of Neural Engineering. In the research paper, “Self-Regulation Of Brain Rhythms In The Precuneus: A Novel BCI Paradigm For Patients…
Long-term use of Rilutek (riluzole) is associated with a better outcome in sporadic amyotrophic lateral sclerosis (ALS) patients, whereas short-term use seems to have little effect on survival according to a study published in the scientific journal Frontiers in Aging Neuroscience.
Vitamin D is often called the “sunshine vitamin” mostly because we can get it naturally when the sun’s UV rays interact with our skin, which triggers the vitamin’s synthesis. The VIP vitamin aids our body’s absorption of calcium to keep our bones strong and encourage healthy cells to grow.  Here are a few more health benefits of…
The ALS Association is awarding a $2 million grant to the ALS ONE-Massachusetts Partnership that will partially sponsor a University of Massachusetts Medical School project led by Robert H. Brown, Jr., MD, PhD, a world-renowned specialist in amyotrophic lateral sclerosis (ALS). The grant will help Brown and colleagues develop two gene…
The European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion recommending that ibudilast (MN-166) receives orphan medicinal product (orphan drug designation) for the treatment of amyotrophic lateral sclerosis (ALS). MediciNova is currently focusing on the development of ibudilast for neurological disorders…
https://vimeo.com/124556645 In this video from the ALS Association Texas chapter shared in 2015, we meet Steve. A recently retired chaplain for the federal prison system from Fort Worth, Texas, Steve is about to get married to his longtime sweetheart, Anna. Meet pastor Kevin Kinchen, who hasn’t let his ALS…
A woman with amyotrophic lateral sclerosis (ALS), who had lost nearly all capacity to communicate, is now able to successfully interact with her surroundings using a brain-computer interface implant, according to a recent article in New Scientist magazine. The device is thought to be the first used in a patient’s daily life, without the need…
